Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
clinical trials
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
raleigh-durham blog main
raleigh-durham top stories
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
What
new
2
×
advantages
bar
bio
biotechs
brings
club
companies
continued
crop
drug
exceeded
expect
firms
gamble
group
haul
ipo
joined
latest
life
market
medco’s
met
million
momentum
mover
nasdaq
neon
offerings
patients
payers
physicians
plan
positive
pricing
projections
public
raised
record
Language
unset
Current search:
investing
×
new
×
" raleigh-durham top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
